![Tim Ayers](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Tim Ayers served as the Chief Compliance Officer & Vice President at Horizon Therapeutics Plc from 2015 to 2018.
He holds a graduate degree from The Trustees of Columbia University in The City of New York and undergraduate and graduate degrees from Georgetown University.
Precedenti posizioni note di Tim Ayers
Società | Posizione | Fine |
---|---|---|
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Responsabile della Conformità | 01/09/2018 |
Formazione di Tim Ayers
Georgetown University | Graduate Degree |
The Trustees of Columbia University in The City of New York | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Horizon Therapeutics Plc
![]() Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Tim Ayers